NCT02915432 2021-12-13The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCCShanghai Junshi Bioscience Co., Ltd.Phase 1/2 Unknown401 enrolled 1 FDA